Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
-Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Medical Advisories
 

Medical Advisory #416
August 23, 2013
Voluntary Recall Issued for Certain Lots of Monoject (TM) Prefill Flush Syringes

Medical Advisory #415
November 16, 2011
Baxter Announces Labeling Error on Sterile Water

Medical Advisory #414
October 26, 2011
Warning about use of Non-sterile Alcohol Wipes

Medical Advisory #413
July 28, 2011
Baxter Voluntarily Recalls One Lot of Recombinate

Medical Advisory #412
January 11, 2011
Recall of Alcohol Prep Pads, Alcohol Swabs and Alcohol Swabsticks Due to Potential Bacterial Contamination

Medical Advisory #411
September 24, 2010
Shortage of DDAVP IV

Medical Advisory #410
January 29, 2010
FDA Issues Recall of Huber Needles and Huber Infusion Sets

Medical Advisory #409
February 18, 2009
Signs of Variant Creutzfeldt-Jakob Disease Found in a UK Patient with Hemophilia: No Added Risk Seen for U.S. Patients

Medical Advisory #408
November 21, 2008
CSL Behring Initiates Field Correction of Component Packs Packaged with Specific Lots of Mononine

Medical Advisory #407
August 20th, 2008
CSL Behring Initiates Voluntary Recall of Specific Lots of Monoclate-P

Medical Advisory #406
November  29, 2006
FDA Confirms Low Risk for Creutzfeldt-Jakob Disease

Medical Advisory #405
June 9, 2006
Novo Nordisk Issues Missing Product Alert

Medical Advisory #404
February 18, 2005
FDA Issues Nationwide Alert for Preloaded Syringes

Medical Advisory #403
January 18, 2005
vCJD Risk Announced for German and Italian users for ZLB product

Medical Advisory #402
December 7, 2004
"Beige Substance" Formation on Certain Butterfly Needles

Medical Advisory #401
October 14, 2004
vCJD Risk Announced for U.K. Plasma Products